Silver Spring Optometry, LLC
Silver Spring Optometry, LLC was paid $59K by Medicaid between Jan 2020 and Jul 2024, across 9 billing codes. Its largest line is V2020, Frames, purchases — 29% of everything it billed.
SILVER SPRING, MD 20910
Next to other Optometrist providers in Maryland
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 283 | $1K | |
| 2021 | 12 | $540.00 | |
| 2022 | 154 | $2K | |
| 2023 | 1,884 | $36K | |
| 2024incomplete | 968 | $19K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| V2020 | Frames, purchases | 29% | 781 | 721 | $17K |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | 23% | 616 | 575 | $13K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 22% | 393 | 344 | $13K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 17% | 260 | 224 | $10K |
| 92015 | Determination of refractive state | 5.2% | 567 | 499 | $3K |
| V2784 | Lens, polycarbonate or equal, any index, per lens | 2.7% | 495 | 458 | $2K |
| S0620 | Routine ophthalmological examination including refraction; new patient | 1.8% | 24 | 24 | $1K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 13 | 13 | $55.76 |
| V2750 | Anti-reflective coating, per lens | 0% | 152 | 133 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.